H.C. Wainwright Remains a Buy on Antares Pharma (ATRS)

In a report released today, Oren Livnat from H.C. Wainwright maintained a Buy rating on Antares Pharma (ATRS – Research Report), with a price target of $5.00. The company’s shares closed last More »

Radius Health (RDUS) Receives a Hold from H.C. Wainwright

H.C. Wainwright analyst Douglas Tsao reiterated a Hold rating on Radius Health (RDUS – Research Report) today and set a price target of $25.00. The company’s shares closed last Friday at $20.60. More »